While Ozempic is FDA-approved for diabetes and Wegovy is approved specifically for weight loss in adults, both utilize the same active ingredient
Most patients regain 5070% of lost weight within 612 months after discontinuing semaglutide, as appetite hormones and food cravings return to baseline
To reduce confusion, enhance clarity, and make this information more accessible, we are in the process of version one of our LNMA reviewing the efficacy and safety of GLP-1 RAs for weight-loss
an FDA advisory committee rejected adding it to the approved compounding list in 2024, citing toxicity and an unresolved cardiac signal
High Court Order Preceded The Recall The recall followed an interim High Court order granted the previous month in litigation brought by Danish pharmaceutical company Novo Nordisk
The use of the GLP-1 program should be done under the supervision and guidance of a medical professional